BackSAB Biotherapeutics Overview

SAB Biotherapeutics Net Tangible Assets

SAB Biotherapeutics's net tangible assets is $230M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$227.25M

Peer average

Loading

SAB Biotherapeutics Net Tangible Assets History

Loading

SAB Biotherapeutics vs. peers: Net Tangible Assets Comparison

Loading

SAB Biotherapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SAB Biotherapeutics (SABS) FAQ

SAB Biotherapeutics (SABS) currently reports a net tangible assets of $230M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore SAB Biotherapeutics's net tangible assets history and peer comparisons.

SAB Biotherapeutics's net tangible assets changed from $0 to $230M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics reported $230M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics, and consider following SABS for alerts when major investors trade the stock.